Skip to main content
SpringerLink
Log in

Clostridium difficile und Antibiotika-assoziierte Colitis bei Risikopatienten: Zweimonatige epidemiologische Studie auf einer Intensiveinheit

Clostridium difficile and antibiotic-associated colitis in high risk patients: epidemiologic study in an intensive care unit over two months

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

A toxin produced by Clostridium difficile has been implicated in the pathogenesis of antibiotic-associated colitis. It is not known how often the microorganism is encountered in Germany particularly in high risk patients. Therefore, following a lethal case of colitis, stool samples of 90 patients and 30 staff members of an intensive care unit were screened routinely for C. difficile over 2 months.

The organism was found in 6 of 41 patients treated with antibiotics (14.6%); four of them apparently acquired C. difficile while in hospital whereas in 2 a pre-existing carrier state could not be excluded. Colitis developed in 3 of the 6 patients as judged from endoscopy or a positive cytotoxin assay; in 2 patients (not subjected to endoscopy) colitis was suspected on clinical grounds, and 1 patient became an asymptomatic carrier. C. difficile was not found in 49 patients without antibiotic medication, in the health personal and in 12 patients of a general ward. Patients harbouring C. difficile were clustered in certain bed sites of the unit. Environmental studies recovered the microorganism from bed pan washing mashines of bedridden and from toilets of ambulant patients but not from other sites like the hands of the personal.

These results suggest that chronic carriers of C. difficile, as far as they are identified by current bacteriological methods, are rare in Germany (not more than 2 out of 132 persons investigated, i.e. 1.5%). The frequent finding of C. difficile in patients treated in certain bed sites supports the view that the infection may be acquired from exogenous sources. Antibiotic-associated colitis should be considered more often when intensive care patients are treated with antibiotics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Literatur

  1. Alpers DH (1978) The pseudomembranous enterocolitides. In: Sleisinger MH, Fordtran JS (eds) Gastrointestinal disease, 2nd edn. Saunders, Philadelphia London Toronto, pp 1715–1730

    Google Scholar 

  2. Bartlett JG, Taylor NS, Chang TW, Dzink JA (1980) Clinical and laboratory observations in clostridium difficile colitis. Am J Clin Nutr 33:2521–2526

    PubMed  Google Scholar 

  3. Bartlett JG, Tedesco FJ, Shull S, Lowe B, Chang TW (1980) Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis. Gastroenterology 78:431–434

    PubMed  Google Scholar 

  4. Burdon DW, George RH, Mogg GAG, Arabi Y, Thompson H, Johnson M, Alexander-Williams J, Keighley MBR (1981) Faecal toxin and severity of antibiotic-associated pseudomembranous colitis. J Clin Pathol 34:548–551

    PubMed  Google Scholar 

  5. Burdon DW, Thompson H, Candy DCA, Kearns M, Lees D, Stephen J (1981) Enterotoxin(s) of clostridium difficile. Lancet 2:258–259

    PubMed  Google Scholar 

  6. Chang TW, Lauermann M, Bartlett JG (1979) Cytotoxicity assay in antibiotic-associated colitis. J Infect Dis 140:765–770

    PubMed  Google Scholar 

  7. Cherry RD, Portnoy D, Jabbari M, Daly DS, Kinnear DG, Goresky CA (1982) Metronidazole: An alternate therapy for antibiotic-associated colitis. Gastroenterology 82:849–851

    PubMed  Google Scholar 

  8. George WL, Rolfe RD, Finegold SM (1980) Treatment and prevention of antimicrobial agent-induced colitis and diarrhea. Gastroenterology 79:366–372

    PubMed  Google Scholar 

  9. George WL, Sutter VL, Citron D, Finegold SM (1979) Selective and differential medium for isolation of clostridium difficile. J Clin Microbiol 9:214–219

    PubMed  Google Scholar 

  10. George WL, Sutter VL, Finegold SM (1978) Toxigenicity and antimicrobial susceptibility of clostridium difficile, a cause of antimicrobial agent-associated colitis. Curr Microbiol 1:55

    Google Scholar 

  11. Greenfield C, Burroughs A, Szawathowski M, Bass N, Noone P, Pounder R (1981) Is pseudomembranous colitis infectious? Lancet 1:371–372

    PubMed  Google Scholar 

  12. Kabins SA, Spira TJ (1975) Outbreak of clindamycin-associated colitis. Ann Int Med 83:830–831

    PubMed  Google Scholar 

  13. Keighley MRB, Burdon DW, Arabi Y, Alexander-Williams J, Thompson H, Youngs D, Johnson M, Bentley S, George RH, Mogg GAG (1978) Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea. Br Med J 2:1667–1669

    PubMed  Google Scholar 

  14. Kim KH, Fekety R, Batts DH, Brown D, Cudmore M, Silva J jr, Waters D (1981) Isolation of clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 143:42–50

    PubMed  Google Scholar 

  15. Larson HE, Price AB (1977) Pseudomembranous colitis: Presence of clostridial toxin. Lancet 2:1312–1314

    PubMed  Google Scholar 

  16. Loeschke K (1982) Diagnostik, Therapie und Epidemiologie der Enterokolitis nach Antibiotika. Inn Med 9:222–228

    Google Scholar 

  17. Loeschke K, Kautz U, Löhrs U (1980) Effects of antibiotics on caecal electrolyte transport and morphology in rats: contribution to the pathogenesis of antibiotic-associated diarrhoea. Klin Wochenschr 58:383–385

    PubMed  Google Scholar 

  18. Lyerly DM, Lockwood DE, Richardson SH, Wilkins TD (1982) Biological activities of toxin A and B of clostridium difficile. Infect Immun 35:1147–1150

    PubMed  Google Scholar 

  19. Mulligan ME, George WL, Rolfe RD, Finegold SM (1980) Epidemiological aspects of clostridium difficile-induced diarrhea and colitis. Am J Clin Nutr 33:2533–2538

    PubMed  Google Scholar 

  20. Rifkin GD, Fekety FR, Silva J jr, Sack RB (1977) Antibiotic-induced colitis. Implication of a toxin neutralised by clostridium sordellii antitoxin. Lancet 2:1103–1106

    PubMed  Google Scholar 

  21. Rogers TR, Petrou M, Lucas C, Chung JTN, Barrett AJ, Boriello SP, Honour P (1981) Spread of clostridium difficile among patients receiving non-absorbable antibiotics for decontamination. Br Med J 283:408–409

    Google Scholar 

  22. Seppälä K, Hjelt L, Sipponen P (1981) Colonscopy in the diagnosis of antibiotic-associated colitis. Scand J Gastroenterol 16:465–468

    PubMed  Google Scholar 

  23. Silva J jr, Fekety R (1981) Clostridia and antimicrobial enterocolitis. Ann Rev Med 32:327–333

    PubMed  Google Scholar 

  24. Taylor NS, Thorne GM, Bartlett JG (1981) Comparison of two toxins produced by clostridium difficile. Infect Immun 34:1036–1043

    PubMed  Google Scholar 

  25. Taylor RH, Borriello SP, Taylor AJ (1981) Isolation of clostridium difficile from the small bowel. Br Med J 283:412

    Google Scholar 

  26. Tedesco FJ (1979) Antibiotic associated pseudomembranous colitis with negative proctosigmoidoscopy examination. Gastroenterology 77:295–297

    PubMed  Google Scholar 

  27. Tedesco F, Markham R, Gurwith M, Christie D, Bartlett JG (1978) Oral vancomycin for antibiotic-associated pseudomembranous colitis. Lancet 2:226–228

    PubMed  Google Scholar 

  28. Tvede M, Willumsen L (1982) Clostridium difficile in patients with irritable bowel syndrome and ulcerative colitis. Lancet 1:1124

    Google Scholar 

  29. Viscidi R, Willey S, Bartlett JG (1981) Isolation rates and toxigenic potential of clostridium difficile isolates from various patient populations. Gastroenterology 81:5–9

    PubMed  Google Scholar 

  30. Willey SH, Bartlett JG (1979) Cultures for clostridium difficile in stools containing a cytotoxin neutralized by clostridium sordellii antitoxin. J Clin Microbiol 10:880–884

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Med. Klinik Innenstadt d. Universität, Ziemssenstr. 1, D-8000, München 2, Bundesrepublik Deutschland

    K. Loeschke, R. Hauck & R. Halbritter

  2. Max-von-Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie der Universität München, Germany

    P. Pfaller & G. Ruckdeschel

Authors
  1. K. Loeschke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Hauck
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Halbritter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Pfaller
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Ruckdeschel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Loeschke, K., Hauck, R., Halbritter, R. et al. Clostridium difficile und Antibiotika-assoziierte Colitis bei Risikopatienten: Zweimonatige epidemiologische Studie auf einer Intensiveinheit. Klin Wochenschr 61, 1081–1087 (1983). https://doi.org/10.1007/BF01496469

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01496469

Key words

Search

Navigation